High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$5.0M
$4,951,402
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CFO
Sell to Cover
|
2026-03-04 | $120,806 | S | Form 4 |
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CFO
Sell to Cover
|
2026-03-04 | $99,442 | S | Form 4 |
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CFO
Sell to Cover
|
2026-03-04 | $72,624 | S | Form 4 |
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CFO
Sell to Cover
|
2026-03-04 | $73,786 | S | Form 4 |
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CFO
Sell to Cover
|
2026-03-04 | $34,881 | S | Form 4 |
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CFO
Sell to Cover
|
2026-03-04 | $36,369 | S | Form 4 |
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CFO
Sell to Cover
|
2026-03-04 | $94,540 | S | Form 4 |
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CFO
Sell to Cover
|
2026-03-04 | $264,901 | S | Form 4 |
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CFO
Sell to Cover
|
2026-03-02 | $176,804 | S | Form 4 |
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CFO
Sell to Cover
|
2026-03-02 | $148,762 | S | Form 4 |
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CFO
Sell to Cover
|
2026-03-02 | $45,362 | S | Form 4 |
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CFO
Sell to Cover
|
2026-03-02 | $17,630 | S | Form 4 |
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CFO
Sell to Cover
|
2026-03-02 | $42,819 | S | Form 4 |
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CFO
Sell to Cover
|
2026-03-02 | $37,055 | S | Form 4 |
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CFO
Sell to Cover
|
2026-03-02 | $77,152 | S | Form 4 |
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CFO
Sell to Cover
|
2026-03-02 | $21,035 | S | Form 4 |
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CFO
Sell to Cover
|
2026-03-02 | $40,257 | S | Form 4 |
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CFO
Sell to Cover
|
2026-03-02 | $115,924 | S | Form 4 |
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CFO
Sell to Cover
|
2026-02-13 | $695,201 | S | Form 4 |
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CFO
Sell to Cover
|
2026-01-12 | $12,772 | S | Form 4 |
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CFO
Sell to Cover
|
2026-01-12 | $10,201 | S | Form 4 |
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CFO
Sell to Cover
|
2026-01-12 | $33,710 | S | Form 4 |
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CFO
Sell to Cover
|
2026-01-12 | $27,702 | S | Form 4 |
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CFO
Sell to Cover
|
2026-01-12 | $27,063 | S | Form 4 |
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CFO
Sell to Cover
|
2026-01-12 | $62,862 | S | Form 4 |
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CFO
Sell to Cover
|
2026-01-12 | $80,949 | S | Form 4 |
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CFO
Sell to Cover
|
2026-01-12 | $56,026 | S | Form 4 |
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CFO
Sell to Cover
|
2026-01-12 | $102,302 | S | Form 4 |
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CFO
Sell to Cover
|
2026-01-12 | $65,422 | S | Form 4 |
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CFO
Sell to Cover
|
2026-01-12 | $48,921 | S | Form 4 |
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CFO
Sell to Cover
|
2026-01-12 | $31,629 | S | Form 4 |
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CFO
Sell to Cover
|
2026-01-12 | $133,163 | S | Form 4 |
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CFO
Sell to Cover
|
2026-01-12 | $148,052 | S | Form 4 |
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CFO
Sell to Cover
|
2026-01-12 | $25,484 | S | Form 4 |
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CFO
Sell to Cover
|
2026-01-12 | $27,922 | S | Form 4 |
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CFO
Sell to Cover
|
2026-01-12 | $62,665 | S | Form 4 |
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CFO
Sell to Cover
|
2026-01-12 | $26,972 | S | Form 4 |
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CFO
Sell to Cover
|
2026-01-12 | $13,351 | S | Form 4 |
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CFO
Sell to Cover
|
2026-01-12 | $2,235 | S | Form 4 |
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CFO
Sell to Cover
|
2026-01-12 | $9,361 | S | Form 4 |
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CFO
Sell to Cover
|
2025-10-02 | $1,831 | S | Form 4 |
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CFO
Sell to Cover
|
2025-10-02 | $87,369 | S | Form 4 |
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CFO
Sell to Cover
|
2025-10-02 | $43,303 | S | Form 4 |
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CFO
Sell to Cover
|
2025-10-02 | $144,184 | S | Form 4 |
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CFO
Sell to Cover
|
2025-10-02 | $194,214 | S | Form 4 |
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CFO
Sell to Cover
|
2025-10-02 | $393,388 | S | Form 4 |
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CFO
Sell to Cover
|
2025-10-02 | $195,204 | S | Form 4 |
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CFO
Sell to Cover
|
2025-10-02 | $317,370 | S | Form 4 |
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CFO
Sell to Cover
|
2025-10-02 | $145,732 | S | Form 4 |
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CFO
Sell to Cover
|
2025-10-02 | $105,012 | S | Form 4 |
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CFO
Sell to Cover
|
2025-10-02 | $32,698 | S | Form 4 |
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CFO
Sell to Cover
|
2025-10-02 | $66,980 | S | Form 4 |